Published in Antioxid Redox Signal on August 01, 2009
Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res (2012) 3.02
Oxidative stress in angiogenesis and vascular disease. Blood (2013) 1.19
Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications. Microcirculation (2010) 1.15
Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med (2012) 1.15
PECAM-targeted delivery of SOD inhibits endothelial inflammatory response. FASEB J (2010) 1.11
The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp Diabetes Res (2012) 1.04
Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling. Diabetes (2012) 1.02
MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK. J Mol Cell Cardiol (2011) 0.96
Critical role of endothelial hydrogen peroxide in post-ischemic neovascularization. PLoS One (2013) 0.92
Cerebral neovascularization in diabetes: implications for stroke recovery and beyond. J Cereb Blood Flow Metab (2014) 0.91
Coronary collateral growth--back to the future. J Mol Cell Cardiol (2011) 0.87
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome? Vascul Pharmacol (2012) 0.87
Corruption of coronary collateral growth in metabolic syndrome: Role of oxidative stress. World J Cardiol (2010) 0.86
Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes. Diabetes (2014) 0.85
Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus. Br J Pharmacol (2015) 0.81
Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-α signaling. Arterioscler Thromb Vasc Biol (2013) 0.79
Placenta growth factor and vascular endothelial growth factor a have differential, cell-type specific patterns of expression in vascular cells. Microcirculation (2014) 0.78
Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox. Am J Physiol Heart Circ Physiol (2015) 0.78
The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction. Am J Physiol Heart Circ Physiol (2015) 0.77
Elevated 20-HETE Impairs Coronary Collateral Growth in Metabolic Syndrome Via Endothelial Dysfunction. Am J Physiol Heart Circ Physiol (2016) 0.75
Cardiovascular function in male and female JCR:LA-cp rats: Effect of high fat/high sucrose diet. Am J Physiol Heart Circ Physiol (2017) 0.75
Nox2 contributes to the arterial endothelial specification of mouse induced pluripotent stem cells by upregulating Notch signaling. Sci Rep (2016) 0.75
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res (2001) 4.22
The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest (1979) 3.87
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation (1993) 3.68
Role of oxidative stress in atherosclerosis. Am J Cardiol (2003) 3.66
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res (2001) 3.39
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest (1998) 3.34
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci (2003) 3.13
Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol (2006) 3.07
Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell (1992) 2.92
Myocardial protection by brief ischemia in noncardiac tissue. Circulation (1996) 2.91
VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene (1999) 2.66
Retracted Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res (2002) 2.56
Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains. Physiol Genomics (2007) 2.46
Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor. Circulation (2003) 2.43
Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol (2004) 2.38
Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem (1999) 2.18
Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res (2004) 2.08
p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem (1998) 2.07
Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation (2000) 2.07
Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation (2000) 2.07
Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med (2006) 2.05
Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res (2006) 2.04
Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation (2005) 1.98
Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med (1990) 1.89
Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res (2004) 1.87
The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth. Arterioscler Thromb Vasc Biol (2007) 1.85
Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res (2001) 1.84
Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res (2008) 1.77
Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch (2000) 1.68
Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem (2001) 1.65
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal (2002) 1.64
The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol (2004) 1.61
Retracted Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2001) 1.55
Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation (1997) 1.51
Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol (2004) 1.51
Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation (2005) 1.48
Mechanisms of myocardial reperfusion injury. Ann Thorac Surg (1999) 1.47
Myocardial micronecrosis produced by microsphere embolization. Role of an alpha-adrenergic tonic influence on the coronary microcirculation. Circ Res (1984) 1.43
Pressure-flow characteristics of coronary collaterals in dogs. Am J Physiol (1989) 1.40
Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol (2005) 1.37
Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation (2003) 1.29
Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem (1998) 1.27
Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol (2003) 1.26
Redox signaling of angiogenesis. Antioxid Redox Signal (2002) 1.25
A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res (1995) 1.22
Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation (2004) 1.17
Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol (2005) 1.16
Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol (2003) 1.16
Arteriogenesis: noninvasive quantification with multi-detector row CT angiography and three-dimensional volume rendering in rodents. Radiology (2006) 1.16
High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimb. Circulation (2006) 1.13
Differential regulation of in vivo angiogenesis by angiotensin II receptors. FASEB J (2003) 1.12
Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol (2007) 1.11
Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol (2007) 1.11
The collateral circulation of the heart. Prog Cardiovasc Dis (1988) 1.07
Therapeutic angiogenesis. Devising new strategies based on past experiences. Basic Res Cardiol (2003) 1.07
Obesity is associated with impaired coronary collateral vessel development. Int J Obes Relat Metab Disord (2003) 1.06
Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis (1995) 1.04
Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD. Basic Res Cardiol (2007) 1.04
Microvascular occlusions promote coronary collateral growth. Am J Physiol (1990) 1.03
The sources of oxidative stress in the vessel wall. Kidney Int (2005) 1.02
Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res (2006) 1.02
Reactive oxygen species are critical mediators of coronary collateral development in a canine model. Am J Physiol Heart Circ Physiol (2003) 0.99
Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler Thromb Vasc Biol (2004) 0.99
Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc Res (2004) 0.98
Heparin-binding epidermal growth factor-like growth factor, collateral vessel development, and angiogenesis in skeletal muscle ischemia. Arterioscler Thromb Vasc Biol (2005) 0.98
Insights into pathways of arteriogenesis. Curr Pharm Biotechnol (2007) 0.98
Impaired collateral artery development in spontaneously hypertensive rats. Microcirculation (2002) 0.97
The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment. Am J Physiol Heart Circ Physiol (2007) 0.94
Ischemia is not required for arteriogenesis in zebrafish embryos. Arterioscler Thromb Vasc Biol (2007) 0.94
VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium. Free Radic Biol Med (2007) 0.94
The art of arteriogenesis. Cell Biochem Biophys (2005) 0.94
Bone marrow transplantation abolishes inhibition of arteriogenesis in placenta growth factor (PlGF) -/- mice. J Mol Cell Cardiol (2003) 0.93
Impaired collateral development in mature rats. Am J Physiol Heart Circ Physiol (2002) 0.92
Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis (2006) 0.92
Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. J Cell Mol Med (2002) 0.92
EC-SOD gene therapy reduces paracetamol-induced liver damage in mice. J Gene Med (2001) 0.91
Coronary collateral flow in response to endurance exercise training. Eur J Cardiovasc Prev Rehabil (2007) 0.91
Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Gene Ther (2007) 0.91
The induction of apoptosis in proliferating human fibroblasts by oxygen radicals is associated with a p53- and p21WAF1CIP1 induction. FEBS Lett (1997) 0.91
Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol (2004) 0.91
Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood (1997) 0.90
Biphasic regulation of angiogenesis by reactive oxygen species. Pharmazie (2006) 0.89
Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium. Am J Physiol (1998) 0.89
Coronary collateral size, flow capacity, and growth: estimates from the angiogram in patients with obstructive coronary disease. Circulation (2002) 0.89
Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med (2005) 0.89
Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis (2005) 0.88
Hypoxia-reoxygenation increases O2-. efflux which injures endothelial cells by an extracellular mechanism. Am J Physiol (1996) 0.88
Improved arteriogenesis with simultaneous skeletal muscle repair in ischemic tissue by SCL(+) multipotent adult progenitor cell clones from peripheral blood. J Vasc Res (2004) 0.86
Nonviral monocyte chemoattractant protein-1 gene transfer improves arteriogenesis after femoral artery occlusion. Gene Ther (2004) 0.86
Absence of functioning alpha-adrenergic receptors in mature canine coronary collaterals. Circ Res (1986) 0.85
DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol (1982) 0.85
Haptoglobin expression and activity during coronary collateralization. Am J Physiol Heart Circ Physiol (2004) 0.85
Glutathione peroxidase-1 expression enhances recovery of human breast carcinoma cells from hyperoxic cell cycle arrest. Free Radic Biol Med (2002) 0.84
Designer blood vessels and therapeutic revascularization. Br J Pharmacol (2003) 0.84
Angiogenesis: bench to bedside, have we learned anything? Toxicol Pathol (2006) 0.84
Arteriogenesis: lessons learned from clinical trials. Endothelium (2003) 0.84
Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther (2003) 0.84
Sevoflurane selectively increases coronary collateral blood flow independent of KATP channels in vivo. Anesthesiology (1999) 0.84
Electrophysiological effects of O2*- on the plasma membrane in vascular endothelial cells. Am J Physiol Heart Circ Physiol (2005) 0.83
Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res (2002) 3.32
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol (2012) 2.93
Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation (2002) 2.35
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A (2006) 2.30
Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation (2007) 2.17
Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res (2006) 2.04
The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth. Arterioscler Thromb Vasc Biol (2007) 1.85
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal (2002) 1.64
Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. Circ Res (2011) 1.62
Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate diet. Am J Physiol Heart Circ Physiol (2007) 1.54
Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol (2006) 1.52
TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol (2005) 1.51
Vascular endothelial growth factor is required for coronary collateral growth in the rat. Circulation (2005) 1.48
Is there a need for another model on the pulsatile nature of coronary blood flow? Am J Physiol Heart Circ Physiol (2006) 1.40
TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol (2007) 1.36
Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation (2004) 1.31
Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2004) 1.29
Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol (2004) 1.26
Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol (2010) 1.25
Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries. J Hypertens (2005) 1.25
H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle. Am J Physiol Heart Circ Physiol (2006) 1.24
Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol (2003) 1.23
Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am J Physiol Heart Circ Physiol (2008) 1.22
Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol (2004) 1.22
Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab Invest (2010) 1.18
Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation (2004) 1.17
Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol (2003) 1.16
H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels. Am J Physiol Heart Circ Physiol (2006) 1.16
Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth. Am J Physiol Heart Circ Physiol (2007) 1.11
Role of focal adhesion kinase in flow-induced dilation of coronary arterioles. Arterioscler Thromb Vasc Biol (2005) 1.11
Redox-dependent coronary metabolic dilation. Am J Physiol Heart Circ Physiol (2007) 1.10
Mysteries in the local control of blood flow: a physiological "whodunit" involving red cell release of ATP? Circ Res (2012) 1.09
Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc Natl Acad Sci U S A (2006) 1.07
MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol (2013) 1.06
Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease. Basic Res Cardiol (2013) 1.05
Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarction. Circ Res (2012) 1.05
The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp Diabetes Res (2012) 1.04
Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD. Basic Res Cardiol (2007) 1.04
Angiostatin is negatively associated with coronary collateral growth in patients with coronary artery disease. Am J Physiol Heart Circ Physiol (2005) 1.01
Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor. Arterioscler Thromb Vasc Biol (2009) 0.99
Reactive oxygen species are critical mediators of coronary collateral development in a canine model. Am J Physiol Heart Circ Physiol (2003) 0.99
Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats. Arterioscler Thromb Vasc Biol (2011) 0.99
Dynamics of flow velocities in endocardial and epicardial coronary arterioles. Am J Physiol Heart Circ Physiol (2004) 0.98
TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol (2012) 0.98
Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome. Am J Physiol Heart Circ Physiol (2009) 0.97
Mechanisms of metabolic coronary flow regulation. J Mol Cell Cardiol (2011) 0.96
PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation. Am J Physiol Cell Physiol (2011) 0.96
MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK. J Mol Cell Cardiol (2011) 0.96
Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2013) 0.94
Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells. Cardiovasc Res (2005) 0.94
Myocardial angiogenesis. Mol Cell Biochem (2004) 0.93
Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity. FASEB J (2007) 0.92
Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome. Am J Physiol Heart Circ Physiol (2011) 0.88
Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice. J Pathol (2012) 0.87
Eicosanoids in metabolic syndrome. Adv Pharmacol (2013) 0.87
Coronary collateral growth--back to the future. J Mol Cell Cardiol (2011) 0.87
Corruption of coronary collateral growth in metabolic syndrome: Role of oxidative stress. World J Cardiol (2010) 0.86
Haptoglobin expression and activity during coronary collateralization. Am J Physiol Heart Circ Physiol (2004) 0.85
Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signal-regulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice. Am J Pathol (2011) 0.85
Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. J Nutr Biochem (2012) 0.85
Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin. Arterioscler Thromb Vasc Biol (2013) 0.84
Slingshot isoform-specific regulation of cofilin-mediated vascular smooth muscle cell migration and neointima formation. Arterioscler Thromb Vasc Biol (2011) 0.84
Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium. Am J Physiol Endocrinol Metab (2009) 0.84
Electrophysiological effects of O2*- on the plasma membrane in vascular endothelial cells. Am J Physiol Heart Circ Physiol (2005) 0.83
Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity. Cardiovasc Res (2002) 0.83
Role of ion channels in coronary microcirculation: a review of the literature. Future Cardiol (2013) 0.83
Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol (2002) 0.83
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Invest New Drugs (2009) 0.82
Angiostatin: a negative regulator of endothelial-dependent vasodilation. Circulation (2003) 0.82
NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets Smad. Circ Res (2005) 0.82
Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes (2013) 0.82
Mechanotransduction via the elastin-laminin receptor (ELR) in resistance arteries. J Biomech (2003) 0.81
Hydrogen peroxide acts as relaxing factor in human vascular smooth muscle cells independent of map-kinase and nitric oxide. Front Biosci (2006) 0.81
Cardiac myocytes control release of endothelin-1 in coronary vasculature. Am J Physiol Heart Circ Physiol (2005) 0.81
Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth. Am J Physiol Heart Circ Physiol (2004) 0.81
Beta-adrenoceptor stimulation of alveolar fluid clearance is increased in rats with heart failure. Am J Physiol Lung Cell Mol Physiol (2009) 0.80
Stimulation of coronary collateral growth by granulocyte stimulating factor: role of reactive oxygen species. Arterioscler Thromb Vasc Biol (2009) 0.80
Chaotic behavior of the coronary circulation. Med Biol Eng Comput (2008) 0.80
The role of mitochondrial bioenergetics and reactive oxygen species in coronary collateral growth. Am J Physiol Heart Circ Physiol (2013) 0.80
Novel thiazolidinedione mitoNEET ligand-1 acutely improves cardiac stem cell survival under oxidative stress. Basic Res Cardiol (2015) 0.79
PPAR-gamma agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts? Am J Physiol Heart Circ Physiol (2006) 0.79